The 25-hydroxyvitamin D3 C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)

Clinica Chimica Acta

Volumn 442, Issue , 2015, Pages 75-81

  Lutsey, Pamela L ^a   Eckfeldt, John H ^b   Ogagarue, Ejovwoke R ^a   Folsom, Aaron R ^a   Michos, Erin D ^c   Gross, Myron ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25 Hydroxyvitamin D3 C 3 epimer; Atherosclerosis Risk in Communities Study (ARIC); Race; Reclassification; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25 HYDROXYVITAMIN D3 C 3 EPIMER; CALCIFEDIOL; UNCLASSIFIED DRUG; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; COMMUNITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE AGED; POPULATION RESEARCH; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; DEMOGRAPHY; RISK; STEREOISOMERISM; TIME;

ATHEROSCLEROSIS; CALCIFEDIOL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RISK; STEREOISOMERISM; TIME FACTORS; VITAMIN D;

EID: 84921851053     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.12.036     Document Type: Article

References (32)

1. Byrd-Bredbenner C., Moe G., Beshgetoor D., Berning J. Wardlaw's perspectives in nutrition 2013, McGraw-Hill, New York. 9th ed.
2. Willett W.C. Nutritional Epidemiology 1998, Oxford University Press, New York. 2nd ed.
3. Office of Dietary Supplements Dietary supplement fact sheet: vitamin D. Supplements OoD 2008, National Institutes of Health. Office of Dietary Supplements (Ed.).
4. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B., Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Dietary reference intakes for calcium and vitamin D: institute of medicine 2010, Institute of Medicine.
5. Bolland M.J., Grey A., Gamble G.D., Reid I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014.
6. Reddy GS, Muralidharan KR, Okamura WH, Tserng K-Y, McLane JA. Metabolism of 1α,25-dihydroxyvitamin D3 and its C-3 epimer 1α,25-dihydroxy-3-epi-vitamin D3 in neonatal human keratinocytes. Steroids.66:441-50.
7. Yetley E.A., Pfeiffer C.M., Schleicher R.L., Phinney K.W., Lacher D.A., Christakos S., et al. NHANES monitoring of serum 25-hydroxyvitamin d: a roundtable summary. J Nutr 2010, 140:2030S-2045S.
8. Stepman H.C., Vanderroost A., Stockl D., Thienpont L.M. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D in serum of infants and adults. Clin Chem Lab Med 2011, 49:253-256.
9. Granado-Lorencio F., Blanco-Navarro I., Pérez-Sacristán B., Donoso-Navarro E., Silvestre-Mardomingo R. Serum levels of 3-epi-25-OH-D3 during hypervitaminosis D in clinical practice. J Clin Endocrinol Metab 2012, 97:E2266-E2270.
10. Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D3 is present in adult serum. J Clin Endocrinol Metab 2012, 97:163-168.
11. Strathmann F.G., Sadilkova K., Laha T.J., LeSourd S.E., Bornhorst J.A., Hoofnagle A.N., et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta; Int J Clin Chem 2012, 413:203-206.
12. Baecher S., Leinenbach A., Wright J.A., Pongratz S., Kobold U., Thiele R. Simultaneous quantification of four vitamin D metabolites in human serum using high performance liquid chromatography tandem mass spectrometry for vitamin D profiling. Clin Biochem 2012, 45:1491-1496.
13. Bailey D., Veljkovic K., Yazdanpanah M., Adeli K. Analytical measurement and clinical relevance of vitamin D3 C3-epimer. Clin Biochem 2013, 46:190-196.
14. Kamao M., Tatematsu S., Hatakeyama S., Sakaki T., Sawada N., Inouye K., et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-EPI-25-hydroxyvitamin D3 and subsequently metabolized through C-1α OR C-24 hydroxylation. J Biol Chem 2004, 279:15897-15907.
15. Brown A.J., Ritter C.S., Weiskopf A.S., Vouros P., Sasso G.J., Uskokovic M.R., et al. Isolation and identification of 1α-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. J Cell Biochem 2005, 96:569-578.
16. Brown A.J., Ritter C., Slatopolsky E., Muralidharan K.R., Okamura W.H., Reddy G.S. 1α,25-Dihydroxy-3-Epi-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 1999, 73:106-113.
17. Astecker N., Satyanarayana Reddy G., Herzig G., Vorisek G., Schuster I. 1α,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1α,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes. Mol Cell Endocrinol 2000, 170:91-101.
18. Hoofnagle A.N., Laha T.J., Donaldson T.F. A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: application to vitamin D testing. J Chromatogr B 2010, 878:1639-1642.
19. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
20. Siedel J., Hagele E.O., Ziegenhorn J., Wahlefeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983, 29:1075-1080.
21. Nagele U., Hagele E.O., Sauer G., Wiedemann E., Lehmann P., Wahlefeld A.W., et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984, 22:165-174.
22. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28:1379-1388.
23. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
24. Inker L.A., Schmid C.H., Tighiouart H., Eckfeldt J.H., Feldman H.I., Greene T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012, 367:20-29.
25. Kasahara A.K., Singh R.J., Noymer A. Vitamin D (25OHD) serum seasonality in the United States. PLoS ONE 2013, 8:e65785.
26. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002, 30:771-777.
27. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91:3055-3061.
28. de la Hunty A., Wallace A.M., Gibson S., Viljakainen H., Lamberg-Allardt C., Ashwell M. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010, 104:612-619.
29. Stamp T.C., Round J.M. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 1974, 247:563-565.
30. Ellis G., Dixon K. Sequential-saturation-type assay for serum 25-hydroxyvitamin D. Clin Chem 1977, 23:855-862.
31. Zerwekh J.E. The measurement of vitamin D: analytical aspects. Ann Clin Biochem 2004, 41:272-281.
32. Bodnar L.M., Catov J.M., Wisner K.L., Klebanoff M.A. Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40years. Br J Nutr 2009, 101:278-284.